Skip to main content

Table 4 Cox regression analyses for hospitalization and mortality in the first year of ART according to urine-LAM result and TB diagnosis category among ART-naïve adults

From: Determine TB-LAM point-of-care tuberculosis assay predicts poor outcomes in outpatients during their first year of antiretroviral therapy in South Africa

 

Unadjusted HR (95% CI)

p-value

Adjusted HR (95% CI)

P-value

Hospitalization at 90 days

 No TB diagnosed

1.0

< 0.001

1.0

0.025

 Urine-LAM negative/TB diagnosed

2.88 (1.55–5.35)

 

1.97 (1.02–3.81)

 

 Urine-LAM positive

5.36 (2.51–11.46)

 

3.09 (1.33–7.17)

 

Hospitalization at one year

 No TB diagnosed

1.0

< 0.001

1.0

< 0.001

 Urine-LAM negative/TB diagnosed

3.35 (2.07–5.41)

 

2.42 (1.45–4.06)

 

 Urine-LAM positive

5.95 (3.29–10.58)

 

3.65 (1.89–7.06)

 

Hospitalization at 90 days among those with microbiologically-confirmed TB (n = 79)

 Urine-LAM negative

1.0

0.07

1.0

0.29

 Urine-LAM positive

2.44 (1.00–5.93)

 

1.75 (0.64–4.78)

 

Hospitalization at one year among those with microbiologically-confirmed TB (n = 79)

 Urine-LAM negative

1.0

0.019

1.0

0.16

 Urine-LAM positive

2.49 (1.22–5.06)

 

1.84 (0.80–4.27)

 

Mortality at 90 days

 No TB diagnosed

1.0

< 0.001

1.0

0.015

 Urine-LAM negative/TB diagnosed

1.23 (0.47–3.20)

 

1.01 (0.37–2.74)

 

 Urine-LAM positive

7.67 (3.48–16.90)

 

3.83 (1.52–9.66)

 

Mortality at one year

 No TB diagnosed

1.0

 

1.0

0.07

 Urine-LAM negative/TB diagnosed

1

 

1.40 (0.74–2.67)

 

 Urine-LAM positive

  

2.60 (1.19–5.66)

 

Mortality at 90 days among those with microbiologically-confirmed TB (n = 79)

 Urine-LAM negative

1.0

0.016

1.0

0.07

 Urine-LAM positive

4.95 (1.43–17.12)

 

3.90 (0.91–16.72)

 

Mortality at one year among those with microbiologically-confirmed TB (n = 79)

 Urine-LAM negative

1.0

0.035

1.0

0.10

 Urine-LAM positive

3.23 (1.17–8.90)

 

2.84 (0.86–9.41)

 
  1. All analyses among n = 468 patients unless explicitly stated otherwise
  2. P-value based on likelihood-ratio test